Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Overview of attention for article published in BMC Musculoskeletal Disorders, July 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 63 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 43 publications that cite this research output.

43

The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.

Serum interα-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis

Article in Scandinavian Journal of Clinical and Laboratory Investigation (December 2023)

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: results from the EuroSpA Research Collaboration Network

Article in RMD Open (December 2023)

A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis

Article in Autoimmunity Reviews (August 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.